Assenagon Asset Management S.A. Sells 211,672 Shares of Masimo Corporation (NASDAQ:MASI)

Assenagon Asset Management S.A. reduced its stake in Masimo Corporation (NASDAQ:MASI) by 98.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,379 shares of the medical equipment provider’s stock after selling 211,672 shares during the period. Assenagon Asset Management S.A.’s holdings in Masimo were worth $730,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of MASI. Empowered Funds LLC grew its stake in shares of Masimo by 85.7% in the 4th quarter. Empowered Funds LLC now owns 3,891 shares of the medical equipment provider’s stock valued at $643,000 after purchasing an additional 1,796 shares during the period. Allspring Global Investments Holdings LLC grew its stake in shares of Masimo by 1,936.9% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 48,764 shares of the medical equipment provider’s stock valued at $8,220,000 after purchasing an additional 46,370 shares during the period. Blue Trust Inc. grew its stake in shares of Masimo by 127.0% in the 4th quarter. Blue Trust Inc. now owns 286 shares of the medical equipment provider’s stock valued at $47,000 after purchasing an additional 160 shares during the period. CIBC Asset Management Inc grew its stake in shares of Masimo by 5.6% in the 4th quarter. CIBC Asset Management Inc now owns 1,631 shares of the medical equipment provider’s stock valued at $270,000 after purchasing an additional 87 shares during the period. Finally, Private Advisor Group LLC grew its position in Masimo by 2.5% during the 4th quarter. Private Advisor Group LLC now owns 4,260 shares of the medical equipment provider’s stock worth $704,000 after acquiring an additional 105 shares during the last quarter. 85.96% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Raymond James Financial decreased their price target on Masimo from $204.00 to $185.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 7th. Needham & Company LLC restated a “hold” rating on shares of Masimo in a research report on Thursday, April 10th. Wells Fargo & Company decreased their price target on Masimo from $205.00 to $190.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 7th. Wall Street Zen lowered Masimo from a “buy” rating to a “hold” rating in a research report on Friday, May 30th. Finally, BTIG Research set a $193.00 price target on Masimo and gave the stock a “buy” rating in a research report on Wednesday, May 7th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $191.60.

Insider Transactions at Masimo

In related news, COO Bilal Muhsin sold 10,000 shares of the firm’s stock in a transaction on Monday, May 12th. The stock was sold at an average price of $163.28, for a total transaction of $1,632,800.00. Following the sale, the chief operating officer now owns 24,172 shares of the company’s stock, valued at approximately $3,946,804.16. This trade represents a 29.26% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 9.70% of the stock is owned by corporate insiders.

Masimo Stock Up 2.2%

Shares of MASI opened at $162.77 on Thursday. The firm has a market capitalization of $8.83 billion, a price-to-earnings ratio of -17.75 and a beta of 1.19. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.62 and a current ratio of 2.17. The business’s fifty day moving average price is $158.65 and its two-hundred day moving average price is $166.93. Masimo Corporation has a 52 week low of $101.61 and a 52 week high of $194.88.

Masimo (NASDAQ:MASI) last posted its quarterly earnings results on Tuesday, May 6th. The medical equipment provider reported $1.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.12. Masimo had a positive return on equity of 22.56% and a negative net margin of 25.06%. The business had revenue of $372.00 million for the quarter, compared to analyst estimates of $367.79 million. During the same period last year, the company earned $0.77 EPS. The firm’s revenue was down 24.5% on a year-over-year basis. On average, analysts predict that Masimo Corporation will post 4.1 earnings per share for the current year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.